Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10147)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
ZEB1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4) [Suppressor]
In total 2 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Osteosarcoma | ICD-11: 2B51 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
SW1353 cells | Bone chondrosarcoma | Homo sapiens | CVCL_0543 | ||
MG-63 cells | Osteosarcoma | Homo sapiens | CVCL_0426 | ||
SAOS-2 cells | Osteosarcoma | Homo sapiens | CVCL_0548 | ||
U2OS cells | Osteosarcoma | Homo sapiens | CVCL_0042 | ||
HOB (Human normal osteoblastic cells) | |||||
In Vivo Model |
The OS model of nude mice was constructed using the CDTX model. After transfection, the h143B cells were prepared into a single-cell suspension and subcutaneously injected into the left proximal tibia of 36 (3 mice per group) 4-weeks-old nude mice (1 x 107 cells per mouse).
Click to Show/Hide
|
||||
Response regulation | MiR-144-3p can induce the occurrence of ferroptosis by negatively regulating the expression of ZEB1, thereby inhibiting the proliferation, migration, and invasion of osteosarcoma (OS) cells. The overexpression of ZEB1 caused the lower expression level of ACSL4 and higher expression level of xCT and GPX4. | ||||
Experiment 2 Reporting the Ferroptosis Target of This Regulator | [2] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Fibrosarcoma | ICD-11: 2B53 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | |
LOX-IMVI cells | Melanoma | Homo sapiens | CVCL_1381 | ||
WI-38 cells | Normal | Homo sapiens | CVCL_0579 | ||
RKN cells | Ovarian leiomyosarcoma | Homo sapiens | CVCL_3156 | ||
KP-4 cells | Pancreatic carcinoma | Homo sapiens | CVCL_1338 | ||
HUVECs (Human umbilical vein endothelial cells) | |||||
BJeH (Human foreskin fibroblasts) | |||||
MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 | ||
NCI-H358 cells | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1559 | ||
HCC4006 cells | Lung adenocarcinoma | Homo sapiens | CVCL_1269 | ||
M000921 cells | Melanoma | Homo sapiens | CVCL_S808 | ||
M980513 cells | Melanoma | Homo sapiens | CVCL_S675 | ||
AA01 (Pancreatic cancer cells) | |||||
AA02 (Pancreatic cancer cells) | |||||
In Vivo Model |
Xenografts for LOXIMVI sgEGFP (WT) and LOXIMVI sgGPX4 (KO) cells were established by injecting 10 million cells in a 1:1 PBS:Matrigel mixture containing 2.5 uM ferrostatin-1 into the flanks of athymic mice (NRC Nude, Taconic). Animals were dosed daily with 2 mg kg-1 ferrostatin-1 by intraperitoneal injections. Tumour volume was measured twice a week.
Click to Show/Hide
|
||||
Response regulation | The resulting dependency of ZEB1-high cells on lipid-peroxidase activity is most effectively exploited by direct inhibition of GPX4 in Fibrosarcoma. | ||||
Long-chain-fatty-acid--CoA ligase 4 (ACSL4) [Driver]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Driver | ||||
Responsed Disease | Osteosarcoma | ICD-11: 2B51 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
SW1353 cells | Bone chondrosarcoma | Homo sapiens | CVCL_0543 | ||
MG-63 cells | Osteosarcoma | Homo sapiens | CVCL_0426 | ||
SAOS-2 cells | Osteosarcoma | Homo sapiens | CVCL_0548 | ||
U2OS cells | Osteosarcoma | Homo sapiens | CVCL_0042 | ||
HOB (Human normal osteoblastic cells) | |||||
In Vivo Model |
The OS model of nude mice was constructed using the CDTX model. After transfection, the h143B cells were prepared into a single-cell suspension and subcutaneously injected into the left proximal tibia of 36 (3 mice per group) 4-weeks-old nude mice (1 x 107 cells per mouse).
Click to Show/Hide
|
||||
Response regulation | MiR-144-3p can induce the occurrence of ferroptosis by negatively regulating the expression of ZEB1, thereby inhibiting the proliferation, migration, and invasion of osteosarcoma (OS) cells. The overexpression of ZEB1 caused the lower expression level of ACSL4 and higher expression level of xCT and GPX4. | ||||
Osteosarcoma [ICD-11: 2B51]
In total 2 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Zinc finger E-box-binding homeobox 1 (ZEB1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
SW1353 cells | Bone chondrosarcoma | Homo sapiens | CVCL_0543 | ||
MG-63 cells | Osteosarcoma | Homo sapiens | CVCL_0426 | ||
SAOS-2 cells | Osteosarcoma | Homo sapiens | CVCL_0548 | ||
U2OS cells | Osteosarcoma | Homo sapiens | CVCL_0042 | ||
HOB (Human normal osteoblastic cells) | |||||
In Vivo Model |
The OS model of nude mice was constructed using the CDTX model. After transfection, the h143B cells were prepared into a single-cell suspension and subcutaneously injected into the left proximal tibia of 36 (3 mice per group) 4-weeks-old nude mice (1 x 107 cells per mouse).
Click to Show/Hide
|
||||
Response regulation | MiR-144-3p can induce the occurrence of ferroptosis by negatively regulating the expression of ZEB1, thereby inhibiting the proliferation, migration, and invasion of osteosarcoma (OS) cells. The overexpression of ZEB1 caused the lower expression level of ACSL4 and higher expression level of xCT and GPX4. | ||||
Experiment 2 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Zinc finger E-box-binding homeobox 1 (ZEB1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
143B cells | Osteosarcoma | Homo sapiens | CVCL_2270 | |
SW1353 cells | Bone chondrosarcoma | Homo sapiens | CVCL_0543 | ||
MG-63 cells | Osteosarcoma | Homo sapiens | CVCL_0426 | ||
SAOS-2 cells | Osteosarcoma | Homo sapiens | CVCL_0548 | ||
U2OS cells | Osteosarcoma | Homo sapiens | CVCL_0042 | ||
HOB (Human normal osteoblastic cells) | |||||
In Vivo Model |
The OS model of nude mice was constructed using the CDTX model. After transfection, the h143B cells were prepared into a single-cell suspension and subcutaneously injected into the left proximal tibia of 36 (3 mice per group) 4-weeks-old nude mice (1 x 107 cells per mouse).
Click to Show/Hide
|
||||
Response regulation | MiR-144-3p can induce the occurrence of ferroptosis by negatively regulating the expression of ZEB1, thereby inhibiting the proliferation, migration, and invasion of osteosarcoma (OS) cells. The overexpression of ZEB1 caused the lower expression level of ACSL4 and higher expression level of xCT and GPX4. | ||||
Fibrosarcoma [ICD-11: 2B53]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [2] | ||||
Target Regulator | Zinc finger E-box-binding homeobox 1 (ZEB1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | |
LOX-IMVI cells | Melanoma | Homo sapiens | CVCL_1381 | ||
WI-38 cells | Normal | Homo sapiens | CVCL_0579 | ||
RKN cells | Ovarian leiomyosarcoma | Homo sapiens | CVCL_3156 | ||
KP-4 cells | Pancreatic carcinoma | Homo sapiens | CVCL_1338 | ||
HUVECs (Human umbilical vein endothelial cells) | |||||
BJeH (Human foreskin fibroblasts) | |||||
MCF-7 cells | Breast carcinoma | Homo sapiens | CVCL_0031 | ||
NCI-H358 cells | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1559 | ||
HCC4006 cells | Lung adenocarcinoma | Homo sapiens | CVCL_1269 | ||
M000921 cells | Melanoma | Homo sapiens | CVCL_S808 | ||
M980513 cells | Melanoma | Homo sapiens | CVCL_S675 | ||
AA01 (Pancreatic cancer cells) | |||||
AA02 (Pancreatic cancer cells) | |||||
In Vivo Model |
Xenografts for LOXIMVI sgEGFP (WT) and LOXIMVI sgGPX4 (KO) cells were established by injecting 10 million cells in a 1:1 PBS:Matrigel mixture containing 2.5 uM ferrostatin-1 into the flanks of athymic mice (NRC Nude, Taconic). Animals were dosed daily with 2 mg kg-1 ferrostatin-1 by intraperitoneal injections. Tumour volume was measured twice a week.
Click to Show/Hide
|
||||
Response regulation | The resulting dependency of ZEB1-high cells on lipid-peroxidase activity is most effectively exploited by direct inhibition of GPX4 in Fibrosarcoma. | ||||
References